1.	AMENO-2: Aprepitant Plus Palonosetron Versus Granisetron in the Prevention of Nausea and the Emesis Induced by Chemotherapy in Patients Treated With Haematopoietic Progenitors Phase: Phase IV Type: Supportive care, Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: 2006-00055-18, NCT00415103
2.	Ginger in Treating Nausea in Patients Receiving Chemotherapy for Cancer Phase: Phase III, Phase II Type: Supportive care Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000069401, U10CA037420, URCC-U1902, URCC-0114, NCI-5857, NCI-P02-0223, NCT00040742
3.	Drugs to Reduce the Side Effects of Chemotherapy Phase: Phase III Type: Supportive care Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: SAKK 90/95, SWS-SAKK-90/95, EU-97035, CDR0000066073, NCT00003213
4.	Phase III Randomized Study of Lerisetron Versus Granisetron Hydrochloride in the Prevention of Radiotherapy Induced Nausea and Vomiting in Men With Stage I Seminoma (Summary Last Modified 07/2000). Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase III Type: Supportive care, Treatment Status: Closed Age: 18 to 70 Sponsor: Other Protocol IDs: SIMBEC-RD526/21494, EU-99027, NCT00004219
5.	Phase III Randomized Study of Granisetron in the Prevention of Nausea and Vomiting Following Cyclophosphamide-Based or Carboplatin-Based Chemotherapy in Patients With Malignant Disease. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase III Type: Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: UCLA-9904005, SB-BRL43694A/513, NCI-G00-1674, NCT00005024
6.	Comparison of Antiemetic Drugs in Preventing Delayed Nausea After Chemotherapy in Patients With Cancer Phase: Phase III Type: Supportive care Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: CDR0000068694, URCC-U3901, NCI-P01-0180, NCT00020657
7.	Granisetron, Dexamethasone, Prochlorperazine, Aprepitant, and Palonosetron in Preventing Nausea in Patients Undergoing Chemotherapy for Breast Cancer Phase: Phase III Type: Supportive care Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000544841, U10CA037420, URCC-04-02, URCC-U1105, U1105, NCT00475085
8.	Acupressure and Acustimulation Wrist Bands for the Prevention of Nausea and Vomiting Caused by Chemotherapy Phase: Phase II Type: Supportive care Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: CDR0000066969, URCC-U3997, NCI-V99-1528, NCT00003817
9.	Phase II Study of CDDP/CBDCA with Ondansetron or Granisetron and G-CSF in Patients with Stage III/IV Epithelial Ovarian Cancer Phase: Phase II Type: Supportive care, Treatment Status: Closed Age: no age specified Sponsor: Other Protocol IDs: NBSG-9204, NCI-V92-0153
10.	Aprepitant, Granisetron, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Cyclophosphamide Before a Stem Cell Transplant Phase: No phase specified Type: Supportive care, Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000456201, P30CA022453, WSU-D-2797, WSU-0504001728, NCT00293384